Publications by authors named "Almudena Gil-Rodriguez"

Claim this Profile
E
Exploring the sensory profile and pharmacogenetic biomarkers in child and youth ADHD patients undergoing methylphenidate (MPH) treatment: a systematic review conducted in European studies.
Sheila Recarey-Rama, Sabela Conde-Pumpido Zubizarreta, Carla Brenlla, Eva Gerpe-Rieiro, Almudena Gil-Rodriguez

J Psychiatr Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Lack of Complete Linkage Disequilibrium Between c.1236G>A and c.1129-5923C>G HapB3 Variants of : A Call to Revise European Pharmacogenetic Guidelines.
Almudena Gil-Rodriguez, Sheila Recarey-Rama, Ana Fernández Montes, Ana Rodríguez-Viyuela, Francisco Barros

Int J Mol Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Population Frequencies Observed in Galicians Compared to Europeans and Spanish from PhotoDPYD Study.
Almudena Gil-Rodriguez, Sheila Recarey-Rama, Ana Rodríguez-Viyuela, Raquel Cruz, Francisco Barros

Pharmaceuticals (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Relevance of Pharmacokinetic Biomarkers in Response to Methadone Treatment: A Systematic Review.
Sheila Recarey-Rama, Jesús Gómez-Trigo, Almudena Gil-Rodriguez, Eduardo Dominguez, Inés Sánchez-Martínez

Pharmaceuticals (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balance of care activity after EMA recommendation for gene testing in Galicia.
Almudena Gil-Rodríguez, Sheila Recarey-Rama, Ana Rodríguez-Viyuela, Francisco Barros, Angel Carracedo

Front Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 Patients.
Alexandre Serra-Llovich, Natalia Cullell, Olalla Maroñas, María José Herrero, Raquel Cruz, Almudena Gil-Rodriguez

Biomedicines· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Status of the implementation of pharmacogenetics in clinical practice in Spain: from regional to national initiatives.
Maria Apellaniz-Ruiz, Jordi Barrachina, Paula Castro-Sanchez, Ana Comes-Raga, Xandra García-González, Almudena Gil-Rodriguez

Drug Metab Pers Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling.
Enrique Bandín-Vilar, Francisco José Toja-Camba, María Vidal-Millares, María José Durán-Maseda, Marta Pou-Álvarez

Psychiatry Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration.
Laura García-Quintanilla, Pablo Almuiña-Varela, Olalla Maroñas, Almudena Gil-Rodriguez, María José Rodríguez-Cid

Invest Ophthalmol Vis Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion of the gene as a likely explanation for the serious side effects of the antipsychotic drug pimozide: a case report.
Fernando Facal, Begoña Portela, Almudena Gil-Rodríguez, Francisco Barros, Olalla Maroñas

Front Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis